摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-Methylsulfanylbenzenesulfinic acid

中文名称
——
中文别名
——
英文名称
3-Methylsulfanylbenzenesulfinic acid
英文别名
3-methylsulfanylbenzenesulfinic acid
3-Methylsulfanylbenzenesulfinic acid化学式
CAS
——
化学式
C7H8O2S2
mdl
——
分子量
188.3
InChiKey
LUVDWIXDKJFYIG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.6
  • 重原子数:
    11
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.14
  • 拓扑面积:
    81.8
  • 氢给体数:
    1
  • 氢受体数:
    4

文献信息

  • [EN] CYCLOPROPYL AMIDE DERIVATIVES<br/>[FR] DÉRIVÉS D'AMIDE CYCLOPROPYLE
    申请人:GENENTECH INC
    公开号:WO2014074715A1
    公开(公告)日:2014-05-15
    The present invention relates to certain cyclopropyl amide compounds, pharmaceutical compositions comprising such compounds, and methods of treating cancer, including leukemias and solid tumors, inflammatory diseases, osteoporosis, atherosclerosis, irritable bowel syndrome, and other diseases and medical conditions, with such compounds and pharmaceutical compositions. The present invention also relates to certain cyclopropyl amide compounds for use in inhibiting nicotinamide phosphoribosyltransferase ("NAMPT").
    本发明涉及某些环丙基酰胺化合物,包括这些化合物的药物组合物,以及使用这些化合物和药物组合物治疗白血病和实体肿瘤、炎症性疾病、骨质疏松症、动脉粥样硬化、肠易激综合征和其他疾病和医疗状况的方法。本发明还涉及某些环丙基酰胺化合物用于抑制烟酰胺磷酸核糖转移酶("NAMPT")。
  • 2-AMINO-N-(ARYLSULFINYL)-ACETAMIDE COMPOUNDS AS INHIBITORS OF BACTERIAL AMINOACYL-TRNA SYNTHETASE
    申请人:Oxford Drug Design Limited
    公开号:US20200039929A1
    公开(公告)日:2020-02-06
    The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to certain 2-amino-N-(arylsulfinyl)-acetamide compounds that, inter alia, inhibit (e.g., selectively inhibit) bacterial aminoacyl-tRNA synthetase (aaRS) (e.g., bacterial leucyl-t RNA synthetase, LeuRS). The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to inhibit (e.g., selectively inhibit) bacterial aminoacyl-tRNA synthetase; to treat disorders that are ameliorated by the inhibition (e.g., selective inhibition) of bacterial aminoacyl-tRNA synthetase; to treat bacterial infections; etc.
查看更多